Oncotarget

Corrections:

Correction: Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma

PDF

Oncotarget. 2018; 9:13101-13101. https://doi.org/10.18632/oncotarget.24572

Metrics: PDF 228 views  |   ?  

Rusdina Bte Ladju1,2, Devis Pascut1, Muhammad Nasrum Massi2, Claudio Tiribelli1 and Caecilia H.C. Sukowati1

1 Fondazione Italiana Fegato, AREA Science Park Basovizza, Trieste, Italy
2 Faculty of Medicine, Hasanuddin University, Makassar, Indonesia

Published: February 26, 2018

This article has been corrected: The updated Acknowledgments information is provided below:

ACKNOWLEDGMENTS

RBL is supported by fellowships from the Lembaga Pengelola Dana Pendidikan (LPDP) of the Indonesian Ministry of Monetary, DP by NECTE project of PAR-FSC_2007-13 decree n° 3984/LAVFOR.ISTR/2014 Friuli Venezia Giulia, CHCS fellowship was partially supported by grant NIH U01AA020821. This work was supported by in-house grant from the Fondazione Italiana Fegato, Trieste, Italy, and the Faculty of Medicine, Hasanuddin University, Makassar, Indonesia.

Original article: Oncotarget. 2018; 9:2951-2961. doi: https://doi.org/10.18632/oncotarget.23359.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 24572